← All stories
Deals
hVIVO acquires CRS Berlin for dermatology, women’s health trials
2 outlets - including Investing and Kalkinemedia - are covering this story. hVIVO plc (AIM: HVO), a global frontrunner in human challenge trials listed on AIM, has completed the acquisition of CRS Clinical Research Services Berlin GmbH, a specialist Phase I/II clinical research unit based in Germany. This strategic…
Covered by 2 outlets
All coverage · 2 articles
Investing.com Canada
·2h ago
hVIVO acquires CRS Berlin for dermatology, women’s health trials
Kalkine Media UK
·2h ago
hVIVO plc (HVO) Expands Dermatology and Women's Health Clinical Trial Services with CRS Berlin Acquisition
hVIVO plc (AIM: HVO), a global frontrunner in human challenge trials listed on AIM, has completed the acquisition of CRS Clinical Research Services Berlin GmbH, a specialist Phase I/II clinical research unit based in Germany. This strategic…